Edit search
Siponimod versus placebo in secondary progressive multiple s…
Siponimod versus placebo in secondary progressive multiple sclerosis %28EXPAND%29%3A a double-blind%2C randomized%2C phase 3 study
Siponimod versus placebo in secondary progressive multiple sclerosis %28EXPAND%29%3A a double-blind%2C randomized%2C phase 3 study
Article, Chapter
Authors: L. Kappos
Publication: Lancet, The, Volume:391, Page(s):1263-1273
Published: Elsevier, 2018
ISSN: 0140-6736
  Full text availability for this item
Browse related articles
  Print copies at your library
  Request a copy of this item
Cite this item